Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)
China · Delayed Price · Currency is CNY 12.88
+0.02 (0.16%)
At close: Feb 27, 2026
SHE:301126 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -4.78 | 26.57 | 34.3 | 51.08 | 68.26 | 64.85 |
Depreciation & Amortization | 145.96 | 145.96 | 83.44 | 42.28 | 22.68 | 12.59 |
Other Amortization | 23.39 | 23.39 | 16.14 | 9.1 | 3.33 | 1.51 |
Loss (Gain) From Sale of Assets | -1.38 | -1.38 | -1.11 | -0.32 | - | 0 |
Asset Writedown & Restructuring Costs | 12.67 | 12.67 | 0.48 | 0.01 | 13.52 | 4.16 |
Loss (Gain) From Sale of Investments | -0.03 | -0.03 | -1.24 | -0.32 | - | - |
Provision & Write-off of Bad Debts | 7.88 | 7.88 | 14.92 | 16.74 | - | - |
Other Operating Activities | 298.52 | 134.42 | 87.39 | 47.37 | 34.96 | 31.55 |
Change in Accounts Receivable | -337.18 | -337.18 | -164.94 | -374.6 | -438.62 | -45.21 |
Change in Inventory | -51.3 | -51.3 | -116.38 | -125.59 | 36.29 | -102.91 |
Change in Accounts Payable | 136.15 | 136.15 | 99.6 | -156.91 | 115.04 | -118.94 |
Change in Other Net Operating Assets | -63.39 | -63.39 | -13.87 | 0.86 | -15.14 | - |
Operating Cash Flow | 156.79 | 24.04 | 27.13 | -493.96 | -161.81 | -151.46 |
Operating Cash Flow Growth | - | -11.39% | - | - | - | - |
Capital Expenditures | -155.07 | -187.14 | -226.7 | -208.73 | -33.29 | -45.95 |
Sale of Property, Plant & Equipment | 1.29 | 1.28 | 0.22 | 0.08 | - | - |
Cash Acquisitions | -56.33 | -496.86 | -412.22 | -127.74 | - | - |
Investment in Securities | -68.12 | 25.5 | 41.1 | -120 | - | - |
Other Investing Activities | -31 | -30.77 | -201.25 | -47.96 | - | - |
Investing Cash Flow | -309.23 | -687.98 | -798.84 | -504.34 | -33.29 | -45.95 |
Long-Term Debt Issued | - | 2,668 | 2,351 | 1,608 | 819.64 | 791.73 |
Short-Term Debt Repaid | - | - | - | - | - | -17.91 |
Long-Term Debt Repaid | - | -1,994 | -1,382 | -780.55 | -788.91 | -553.85 |
Total Debt Repaid | -2,541 | -1,994 | -1,382 | -780.55 | -788.91 | -571.76 |
Net Debt Issued (Repaid) | 282.09 | 674.01 | 968.66 | 827.08 | 30.73 | 219.97 |
Issuance of Common Stock | - | - | - | 0.49 | 596.17 | - |
Repurchase of Common Stock | -11.91 | -10.01 | - | - | - | - |
Common Dividends Paid | -154.06 | -92.35 | -72.45 | -41.22 | -30.97 | -30.97 |
Dividends Paid | -154.06 | -92.35 | -72.45 | -41.22 | -30.97 | -30.97 |
Other Financing Activities | -31.88 | -0.65 | -31.74 | - | 102.9 | 75.31 |
Financing Cash Flow | 84.24 | 571 | 864.47 | 786.34 | 698.83 | 264.32 |
Net Cash Flow | -68.19 | -92.94 | 92.76 | -211.96 | 503.73 | 66.9 |
Free Cash Flow | 1.72 | -163.1 | -199.57 | -702.69 | -195.1 | -197.41 |
Free Cash Flow Margin | 0.03% | -3.12% | -5.11% | -21.34% | -7.53% | -8.44% |
Free Cash Flow Per Share | 0.01 | -0.80 | -0.99 | -3.44 | -1.26 | -1.28 |
Cash Income Tax Paid | 146.74 | 129.84 | 99.43 | 88.67 | 80.45 | 129.62 |
Levered Free Cash Flow | -40.41 | -271.24 | 27.05 | -643.98 | -59.8 | -186.25 |
Unlevered Free Cash Flow | 29.97 | -203.85 | 70.5 | -618.51 | -38 | -166.53 |
Change in Working Capital | -325.42 | -325.42 | -207.19 | -659.91 | -304.56 | -266.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.